Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated December 5, 2023, serves as a report of a foreign private issuer. The filing announces the commencement of mailing notices for the Company's Combined Ordinary and Extraordinary General Meeting scheduled for December 22, 2023, in Paris, France.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding shareholder meetings and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing.
Guidance, Outlook, and Management Commentary
The filing contains no management commentary on business outlook, risks, contingencies, or unusual items. The primary content is the notification of the General Meeting and the attachment of the meeting notice and proxy materials.
Key Facts for Investor Verification
- General Meeting Date: December 22, 2023.
- Meeting Time: 2:30 p.m. (Paris time).
- Meeting Location: Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.
- Documents Mailed: General Meeting Notice (Exhibit 99.1) and Proxy Card with Voting Instructions (Exhibit 99.2).
- Signatory: André Choulika, Chief Executive Officer.